Antimicrob Agents Chemother

1. VILLELLAS C, Stevenaert F, Remmerie B, Andries K, et al
   Sub-MIC levels of bedaquiline and clofazimine can select Mycobacterium tuberculosis mutants with increased MIC.
   Antimicrob Agents Chemother. 2024 Mar 12:e0127523. doi: 10.1128/aac.01275.
   

   >> Share

   
   

   
   Clin Infect Dis

2. NGO HX, Xu AY, Velasquez GE, Zhang N, et al
   Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
   Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093.
   

   >> Share

   
   

   
   Int J Tuberc Lung Dis

3. LEAVITT SV, Rodriguez CA, Bouton TC, Horsburgh CR, et al
   Outcomes for people with TB by disease severity at presentation.
   Int J Tuberc Lung Dis. 2024;28:142-147.
   

   >> Share

   
   
4. RUDOLF F, Abate E, Moges B, Gomes VF, et al
   A structured 2-week follow-up visit in the cascade of care for TB increases case detection.
   Int J Tuberc Lung Dis. 2024;28:148-153.
   

   >> Share

   
   
5. REZAEE M, Azizi N, Danaei B, Davari A, et al
   TB and interstitial lung disease: a systematic review and meta-analysis.
   Int J Tuberc Lung Dis. 2024;28:130-135.
   

   >> Share

   
   
6. YAMKOVOY K, Self JL, Jenkins HE, Horsburgh CR, et al
   Patterns of TB transmission in the United States, 2011-2017.
   Int J Tuberc Lung Dis. 2024;28:154-156.
   

   >> Share

   
   
7. LEVER S, Akkerman OW, Dekkers BGJ
   Pancreatitis delays the absorption of first-line anti-TB drugs.
   Int J Tuberc Lung Dis. 2024;28:163-165.
   

   >> Share

   
   
8. THOMSON H, Baines N, Huisamen T, Koegelenberg CFN, et al
   A new understanding of clinical patterns in post-TB lung disease.
   Int J Tuberc Lung Dis. 2024;28:115-121.
   

   >> Share

   
   
9. SOUSA S, Santos S, Alves CM, Goncalves G, et al
   Impact of annual TB screening on stone quarry workers in high-incidence Portuguese municipalities.
   Int J Tuberc Lung Dis. 2024;28:136-141.
   

   >> Share

   
   
10. THEKKUR P, Thiagesan R, Nair D, Karunakaran N, et al
    Using timeliness metrics for household contact tracing and TB preventive therapy in the private sector, India.
    Int J Tuberc Lung Dis. 2024;28:122-139.
    

    >> Share

    
    
11. PONTALI E, Akkerman OW, Zenner D, Migliori GB, et al
    Post-TB lung disease: keep going beyond TB!
    Int J Tuberc Lung Dis. 2024;28:113-114.
    

    >> Share

    
    
12. OTA M, Hirao S, Uchimura K
    Lower TB notification rates in later life in the same birth cohort, Japan, 1950-2020.
    Int J Tuberc Lung Dis. 2024;28:157-159.
    

    >> Share

    
    

    
    J Antimicrob Chemother

13. YUNIVITA V, Gafar F, Santoso P, Chaidir L, et al
    Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia.
    J Antimicrob Chemother. 2024 Mar 9:dkae057. doi: 10.1093.
    

    >> Share

    
    

    
    J Clin Microbiol

14. WOOD RC, Luabeya AK, Dragovich RB, Olson AM, et al
    Diagnostic accuracy of tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert MTB/RIF Ultra and Molbio Truenat MTB Ultima.
    J Clin Microbiol. 2024 Mar 14:e0001924. doi: 10.1128/jcm.00019.
    

    >> Share

    
    
15. LUUKINEN B, Antikainen J, Aittoniemi J, Miikkulainen-Lahti T, et al
    Evaluation of the FluoroType Mycobacteria assay for identification of mycobacteria.
    J Clin Microbiol. 2024;62:e0105423.
    

    >> Share

    
    
16. DESRUISSEAUX C, Broderick C, Lavergne V, Sy K, et al
    Retrospective validation of MetaSystems' deep-learning-based digital microscopy platform with assistance compared to manual fluorescence microscopy for detection of mycobacteria.
    J Clin Microbiol. 2024;62:e0106923.
    

    >> Share

    
    

    
    Lancet

17. SUBBARAMAN R, Fielding K
    Putting technology to the test in tuberculosis care.
    Lancet. 2024;403:878-879.
    

    >> Share

    
    

    
    PLoS One

18. OSMAN M, Meehan SA, von Delft A, Preez KD, et al
    Correction: Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa.
    PLoS One. 2024;19:e0300768.
    

    >> Share

    
    
19. CUNHA R, Filho DBM, M Albuquerque MFP, Lacerda HR, et al
    The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.
    PLoS One. 2024;19:e0299244.
    

    >> Share

    
    
20. KAUMBA PC, Siameka D, Kagujje M, Chungu C, et al
    Knowledge, attitudes, and practices towards childhood tuberculosis among healthcare workers at two primary health facilities in Lusaka, Zambia.
    PLoS One. 2024;19:e0287876.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

21. PATTERSON B, Dinkele R, Gessner S, Koch A, et al
    Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status.
    Proc Natl Acad Sci U S A. 2024;121:e2314813121.
    

    >> Share

    
    

    
    Trop Med Int Health

22. OH AL, Makmor-Bakry M, Islahudin F, Ting CY, et al
    Characteristics, predictors and consequences of tuberculosis treatment interruption: A multicentre retrospective cohort study.
    Trop Med Int Health. 2024 Mar 12. doi: 10.1111/tmi.13987.
    

    >> Share

    
    
23. KERSCHBERGER B, Vambe D, Schomaker M, Mabhena E, et al
    Sustained high fatality during TB therapy amid rapid decline in TB mortality at population level: A retrospective cohort and ecological analysis from Shiselweni, Eswatini.
    Trop Med Int Health. 2024;29:192-205.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share